Drupal.behaviors.print = function(context) {window.print();window.close();}>
Miragen, UT Southwestern Show miR-208 Inhibition Improves Survival in Rodent Heart-Failure Models
September 08, 2011
Miragen, UT Southwestern Show miR-208 Inhibition Improves Survival in Rodent Heart-Failure Models
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Santaris, Miragen Expand microRNA Partnership to Include Additional Targets
January 10, 2013 / Gene Silencing News
In 2012, Top microRNA Drug Developers Pull in Nearly $150M in Funding
December 20, 2012 / Gene Silencing News
Mirna Closes $34.5M Series C Round as microRNA Drugs Gain Investor Interest
October 25, 2012 / Gene Silencing News
Miragen, UT Southwestern Team Publishes Data Linking miR-15 to Cardiomyogenesis
July 28, 2011 / Gene Silencing News
Rosetta Study Suggests miRNAs Can Be Used to ID, Stratify Heart Failure Patients
July 28, 2011 / Gene Silencing News